Dr. Goldberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23600 Telo Ave
Ste 100
Torrance, CA 90505Phone+1 310-543-2611Fax+1 310-543-2056
Summary
- Dr. Damien Goldberg currently is a board certified ophthalmologist in Torrance, California and a managing partner at Wolstan and Goldberg Eye Associates. He is known as a leader in laser vision correction surgery, refractive cataract surgery, and new techniques in corneal surgery and micro-invasive glaucoma surgery.
For patient convenience, Dr. Goldberg maintains surgical credentials at Torrance Memorial, Little Company of Mary Hospital, UCLA, Torrance Surgery Center, Surgery Center of the South Bay, and NVISION. Dr. Goldberg also serves as the Chief of Department at Torrance Memorial, an Affiliate of Cedar Sinai Medical Center.
Dr. Goldberg has an extensive background in research and has been a principle investigator in over eighty FDA clinical trials for new medical devices and medications.
Dr. Goldberg currently sits on the American Society of Cataract and Refractive Surgery (ASCRS) FDA committee. Dr. Goldberg is currently welcoming new patients at Wolstan and Goldberg Eye Associates.
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Cornea, External Diseases, and Refractive Surgery, 2004 - 2005
- MedStar Health/Georgetown-Washington Hospital CenterResidency, Ophthalmology, 2001 - 2004
- Georgetown UniversityMBA, Business, 1997 - 2000
- Georgetown University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2004 - 2026
- DC State Medical License 2003 - 2006
- TX State Medical License 2004 - 2006
- VA State Medical License 2000 - 2001
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors Castle Connolly, 2017-2022
- 300 Innovators in Refractive Surgery OSN Premier Surgeons, 2016
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma Start of enrollment: 2013 Dec 01
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation Start of enrollment: 2014 May 01
- Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 81 citationsBimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical TrialRichard A. Lewis, William C. Christie, Douglas G. Day, E. Randy Craven, Thomas Walters
American Journal of Ophthalmology. 2017-03-01 - 123 citationsDysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatmentMark S. Milner, Kenneth A Beckman, Jodi Luchs, Quentin B. Allen, Richard M. Awdeh
Current Opinion in Ophthalmology. 2017-01-01 - 54 citationsMulticenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery.Syd L Tyson, Shamik Bafna, Joseph P Gira, Damien F. Goldberg, Jason J. Jones
Journal of Cataract and Refractive Surgery. 2019-02-01
Press Mentions
- The First 5-Year Flash MobMarch 18th, 2016
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: